KWIK, M., S. HAINZL, Jan OPPELT, Boris TICHÝ, U. KOLLER, E. BERNARDINELLI, M. STEINER, G. ZARA, C. NOFZIGER, S. WEIS, M. PAULMICHL, S. DOSSENA, W. PATSCH and S.M. SOYAL. Selective Activation of CNS and Reference PPARGC1A Promoters Is Associated with Distinct Gene Programs Relevant for Neurodegenerative Diseases. International Journal of Molecular Sciences. Basel: Multidisciplinary Digital Publishing Institute, 2021, vol. 22, No 7, p. 3296-3319. ISSN 1422-0067. Available from: https://dx.doi.org/10.3390/ijms22073296.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Selective Activation of CNS and Reference PPARGC1A Promoters Is Associated with Distinct Gene Programs Relevant for Neurodegenerative Diseases
Authors KWIK, M., S. HAINZL, Jan OPPELT (203 Czech Republic, belonging to the institution), Boris TICHÝ (203 Czech Republic, guarantor, belonging to the institution), U. KOLLER, E. BERNARDINELLI, M. STEINER, G. ZARA, C. NOFZIGER, S. WEIS, M. PAULMICHL, S. DOSSENA, W. PATSCH and S.M. SOYAL.
Edition International Journal of Molecular Sciences, Basel, Multidisciplinary Digital Publishing Institute, 2021, 1422-0067.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 6.208
RIV identification code RIV/00216224:14740/21:00124256
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.3390/ijms22073296
UT WoS 000638669100001
Keywords in English PPARGC1A; PGC-1α CNS-specific transcripts and isoforms; CRISPR; RNA sequencing; RNA expression; exon usage; neurodegenerative diseases
Tags CF BIOIT, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 18/5/2022 13:39.
Abstract
The transcriptional regulator peroxisome proliferator activated receptor gamma coactivator 1A (PGC-1 alpha), encoded by PPARGC1A, has been linked to neurodegenerative diseases. Recently discovered CNS-specific PPARGC1A transcripts are initiated far upstream of the reference promoter, spliced to exon 2 of the reference gene, and are more abundant than reference gene transcripts in post-mortem human brain samples. The proteins translated from the CNS and reference transcripts differ only at their N-terminal regions. To dissect functional differences between CNS-specific isoforms and reference proteins, we used clustered regularly interspaced short palindromic repeats transcriptional activation (CRISPRa) for selective endogenous activation of the CNS or the reference promoters in SH-SY5Y cells. Expression and/or exon usage of the targets was ascertained by RNA sequencing. Compared to controls, more differentially expressed genes were observed after activation of the CNS than the reference gene promoter, while the magnitude of alternative exon usage was comparable between activation of the two promoters. Promoter-selective associations were observed with canonical signaling pathways, mitochondrial and nervous system functions and neurological diseases. The distinct N-terminal as well as the shared downstream regions of PGC-1 alpha isoforms affect the exon usage of numerous genes. Furthermore, associations of risk genes of amyotrophic lateral sclerosis and Parkinson's disease were noted with differentially expressed genes resulting from the activation of the CNS and reference gene promoter, respectively. Thus, CNS-specific isoforms markedly amplify the biological functions of PPARGC1A and CNS-specific isoforms and reference proteins have common, complementary and selective functions relevant for neurodegenerative diseases.
PrintDisplayed: 20/5/2024 03:05